doi: 10.18632/aging.103064
Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture
[] Anxiety 3.8% of people worldwide suffer from anxiety disorders, which include separation anxiety disorder, specific phobia, social anxiety disorder, panic disorder, agoraphobia, generalised anxiety disorder, substance/medication-induced anxiety disorder and anxiety disorder
Supports tendon, ligament, and muscle healing
These symptoms have many causes, so a blood test is the only way to confirm a deficiency
For most Tirzepatide stacking protocols, I recommend injectable secretagogues like CJC-1295 and Ipamorelin over MK-677